Attachment for esophageal dilatation

Utility and safety of endoscopic attachment for dilatation of esophageal stricture after endoscopic treatment

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs052190063

Enrollment

Registered

2019-10-16

Start date

2020-04-28

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esophageal cancer Esophageal cancer

Interventions

Esophageal dilatation using specific attachment equipped at the tip of endoscope.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Esophageal stricture after esophageal endoscopic treatment. Patients have stricture symptom (Dysphagia score of 2 or more). 2) Strictures are located in thoracic and/or abdominal esophagus. 3) No organ failure 4) 20 years or more, 90 years old or less 5) Written informed consent had been obtained

Exclusion criteria

Exclusion criteria: 1) Stricture is derived from esophageal cancer itself and chemoradiotherapy. 2) Ulcer after endoscopic treatment. 3) Cancers in other organs with life expectancy of three months or less 4) Severe stricture less than 6mm 5) Inadequate case judged by investigators

Design outcomes

Primary

Measure	Time frame
Success rate of esophageal dilatation	—

Secondary

Measure	Time frame
Adverse events. Features of successful and unsuccessful cases.	—

Contacts

Public ContactRyu Ishihara

Osaka International Cancer Institute

ryu1486@gmail.com+81-6-6945-1181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026